- Home
- AFG vs MRNA Comparison
AFG vs MRNA Comparison
Compare AFG & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFG
- MRNA
- Stock Information
- Founded
- AFG 1872
- MRNA 2010
- Country
- AFG United States
- MRNA United States
- Employees
- AFG N/A
- MRNA N/A
- Industry
- AFG Property-Casualty Insurers
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AFG Finance
- MRNA Health Care
- Exchange
- AFG Nasdaq
- MRNA Nasdaq
- Market Cap
- AFG 10.3B
- MRNA 10.6B
- IPO Year
- AFG N/A
- MRNA 2018
- Fundamental
- Price
- AFG $123.88
- MRNA $25.90
- Analyst Decision
- AFG Hold
- MRNA Hold
- Analyst Count
- AFG 4
- MRNA 19
- Target Price
- AFG $138.75
- MRNA $48.13
- AVG Volume (30 Days)
- AFG 482.7K
- MRNA 10.5M
- Earning Date
- AFG 08-05-2025
- MRNA 07-31-2025
- Dividend Yield
- AFG 7.37%
- MRNA N/A
- EPS Growth
- AFG N/A
- MRNA N/A
- EPS
- AFG 9.52
- MRNA N/A
- Revenue
- AFG $7,984,000,000.00
- MRNA $3,177,000,000.00
- Revenue This Year
- AFG N/A
- MRNA N/A
- Revenue Next Year
- AFG $6.40
- MRNA $9.87
- P/E Ratio
- AFG $12.99
- MRNA N/A
- Revenue Growth
- AFG 4.76
- MRNA N/A
- 52 Week Low
- AFG $114.73
- MRNA $23.15
- 52 Week High
- AFG $150.19
- MRNA $138.07
- Technical
- Relative Strength Index (RSI)
- AFG 49.20
- MRNA 46.10
- Support Level
- AFG $121.98
- MRNA $25.06
- Resistance Level
- AFG $125.01
- MRNA $28.72
- Average True Range (ATR)
- AFG 2.15
- MRNA 1.18
- MACD
- AFG 0.04
- MRNA -0.18
- Stochastic Oscillator
- AFG 51.70
- MRNA 20.34
About AFG American Financial Group Inc.
American Financial Group Inc is a holding company that is engaged in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The Company operates through two segments: Property & Casualty Insurance and Other. The Property & Casualty segment includes Property & Transportation, covering buses, trucks, marine, agriculture, and commercial property; Specialty Casualty, offering excess & surplus, liability, and professional insurance; and Specialty Financial, providing risk management for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company's insurance operations are conducted through the Great American Insurance Group.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.